The SARS-CoV-2 as an instrumental trigger of autoimmunity

A Dotan, S Muller, D Kanduc, P David, G Halpert… - Autoimmunity …, 2021 - Elsevier
Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state
of the immune system. It had been established long ago that viruses are a substantial …

[HTML][HTML] SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

[HTML][HTML] Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …

Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review

Y Rodríguez, M Rojas, S Beltrán, F Polo… - Journal of …, 2022 - Elsevier
Autoimmunity linked to COVID-19 immunization has been recorded throughout the
pandemic. Herein we present six new patients who experienced relapses of previous …

[HTML][HTML] Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - nature.com
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

[HTML][HTML] Update advances on C-reactive protein in COVID-19 and other viral infections

Y Luan, C Yin, Y Yao - Frontiers in Immunology, 2021 - frontiersin.org
Severe coronavirus disease 2019 (COVID-19) can manifest as a viral-induced
hyperinflammation with multiorgan dysfunction. It has been documented that severe COVID …

[HTML][HTML] Musculoskeletal involvement of COVID-19: review of imaging

SL Ramani, J Samet, CK Franz, C Hsieh, CV Nguyen… - Skeletal Radiology, 2021 - Springer
The global pandemic of coronavirus disease 2019 (COVID-19) has revealed a surprising
number of extra-pulmonary manifestations of severe acute respiratory syndrome coronavirus …

[HTML][HTML] Proposal of the definition for COVID-19-associated coagulopathy

T Iba, TE Warkentin, J Thachil, M Levi… - Journal of clinical …, 2021 - mdpi.com
Thrombotic events are common complications in COVID-19 patients that include both
thrombus formation in large vessels and the microvasculature of the lung and other organs …

[HTML][HTML] COVID-19 convalescent plasma composition and immunological effects in severe patients

Y Acosta-Ampudia, DM Monsalve, M Rojas… - Journal of …, 2021 - Elsevier
Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the
composition and mechanism of action are not fully known. Therefore, we undertook a two …

[HTML][HTML] Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID

A Vojdani, E Vojdani, E Saidara, M Maes - Viruses, 2023 - mdpi.com
A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a
significant percentage of individuals within a few months after infection with SARS-CoV-2 …